Immediate Impact

19 by Nobel laureates 39 from Science/Nature 62 standout
Sub-graph 1 of 20

Citing Papers

Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
2021 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
12 intermediate papers

Works of Daniel A. Filippa being referenced

Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
2004
ATIC-ALK: A Novel Variant ALK Gene Fusion in Anaplastic Large Cell Lymphoma Resulting from the Recurrent Cryptic Chromosomal Inversion, inv(2)(p23q35)
2000
and 2 more

Author Peers

Author Last Decade Papers Cites
Daniel A. Filippa 3518 2319 1266 82 5.1k
Robert J. Lukes 3861 2190 1570 89 6.0k
Jerome S. Burke 3320 1989 1553 86 5.2k
Risa B. Mann 3064 2740 1154 77 5.5k
Costan W. Berard 3719 2495 1783 110 6.6k
Gregory A. Wiseman 3993 2583 1010 109 8.3k
A G Stansfeld 2937 1643 1181 87 4.8k
Marco Paulli 3742 2723 1443 195 6.4k
Christiane Copie‐Bergman 2923 1842 777 123 4.3k
Sherrie L. Perkins 3603 2505 1333 197 7.2k
Markus Tiemann 2373 2125 652 132 4.2k

All Works

Loading papers...

Rankless by CCL
2026